Skip to content
Lower risk Medical device recall · FDA · Published January 20, 2026

Siemens Atellica CH Urine Albumin Recall: False Low Results Risk

Siemens Healthcare recalls Atellica CH Urine Albumin (UAlb) with material number 11537225 due to potential false low results in urine albumin tests. All units are affected.

🇺🇸 FDA recall #Z-1484-2026Medical deviceSiemens Healthcare ›
Take action

Contact the company

Recalling firmSiemens Healthcare Diagnostics, Inc.511 Benedict Ave · Tarrytown, NY 10591-5005
✎ GovInfoNow plain-language explainer

Siemens Healthcare is recalling its Atellica CH Urine Albumin (UAlb) test device because it may show falsely low urine albumin levels. This could lead to incorrect health assessments if samples have high albumin concentrations. Read more at govinfonow.com/recall/50136-siemens-atellica-ch-urine-albumin-recall-false-low-results-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/50136-siemens-atellica-ch-urine-albumin-recall-false-low-results-risk · Updated August 17, 2026 · FDA enforcement record: FDA #Z-1484-2026

Cite this page

“Siemens Atellica CH Urine Albumin Recall: False Low Results Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/50136-siemens-atellica-ch-urine-albumin-recall-false-low-results-risk. Based on FDA recall #Z-1484-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1484-2026%22&limit=1).

The FDA announced on Jan. 20, 2026, that Siemens Healthcare Diagnostics, Inc. is recalling Atellica CH Urine Albumin (UAlb) material number 11537225. The device may produce falsely depressed urine albumin results for samples with concentrations above 40.0 mg/dL.

How to tell if you have it

  • Brand: Siemens Healthcare
  • Product: Atellica CH Urine Albumin (UAlb)
  • Material Number: 11537225
  • UDI-DI: 00630414611099
  • Lot Numbers: All lot numbers
  • Quantity: 4,885 units

The hazard

According to the FDA, affected samples with any urine albumin concentration above the UAlb measuring interval of >40.0 mg/dL may report values between 6.2 mg/dL and 40.0 mg/dL. This falsely depressed result could lead to incorrect patient assessment.

Context

GovInfoNow's records show Siemens Healthcare Diagnostics, Inc. has 150 other recalls on record since June 7, 2017. Other recent recalls of similar products include Atellica CH Revised C-Reactive Protein (RCRP) recall (Aug. 17, 2026), Siemens Healthcare Syva EMIT 2000 Quinidine Assay Recall (July 13, 2026), and Atellica CH Urine Albumin Recall (July 6, 2026). Other recent recalls of similar products include Changchun Wancheng Bio-Electron UTI Test Strips Recall (Nov. 22, 2025), LH One Step Ovulation Test Device Recall (Nov. 22, 2025), and Menopause Test Cassette Recall (Nov. 22, 2025).

How to tell if you have this one

Check for the material number 11537225 on the device. All lot numbers are affected, so every unit of this product is included in the recall.

  • Brand
    Siemens Healthcare
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Device Details

    Look for the material number 11537225 on the Atellica CH Urine Albumin device.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Canada, Chile, Curacao,¿St¿Eus, Czech¿Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Korea, Latvia,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 50 days after the firm started it.

1. Firm started the recall: Jan 20, 202612. FDA classified it Class II: Mar 2, 202623. Published in FDA’s Enforcement Report: Mar 11, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1484-2026 (January 20, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1484-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA